Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 4/20 | 0.50 |
| ▸ | LGALS9 | O00182 | 2/20 | 0.50 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.50 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14819156 | 1.00 | LGALS3 (0.50) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPOLB | |
| SCHEMBL7889307 | 0.92 | LMNA (0.44) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPOLB | |
| SCHEMBL19613777 | 0.91 | LMNA (0.44) | LGALS3LGALS9LGALS1LGALS7; LGALS7BPOLB | |
| SCHEMBL26099254 | 0.86 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL18934785 | 0.86 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL19067254 | 0.86 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL14819214 | 0.86 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS4 | |
| SCHEMBL7891001 | 0.84 | MAPK1 (0.47) | LGALS3POLBLGALS4MAPK1 | |
| SCHEMBL7890998 | 0.84 | MAPK1 (0.47) | LGALS3POLBLGALS4MAPK1 | |
| SCHEMBL967108 | 0.83 | MAG (0.50) | LGALS3POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9695208-B2 | Sialic acid (A-(2-6))-D-aminopyranose derivatives, synthesis methods and uses thereof | PEKING UNIVERSITY (CN) | 2017-07-04 | — | — | US | disclosed |
| EP-2581380-B1 | SIALIC ACID (alpha-(2-6))-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | UNIV BEIJING (CN) | 2017-06-07 | — | — | EP | disclosed |
| EP-2581380-A1 | SIALIC ACID ( -(2 6)-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | Peking University (CN) | 2013-04-17 | — | — | EP | disclosed |
| US-20130079291-A1 | SIALIC ACID (A-(2-6))-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | PEKING UNIVERSITY (CN) | 2013-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130079291-A1 | SIALIC ACID (A-(2-6))-D-AMINOPYRANOSE DERIVATIVES, SYNTHESIS METHODS AND USES THEREOF | ST6GAL1, FUT6, B3GNT2 | LGALS3 174/4885LGALS9 96/4885LGALS1 87/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.